StockDuty ← Dashboard Sep 22, 2026 04:42 AM ET
SignalCorporate

PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy

PTC completes ST-920 Fabry disease gene therapy acquisition, expanding rare disease pipeline.

PTC completes ST-920 Fabry disease gene therapy acquisition, expanding rare disease pipeline.
PTC completes ST-920 Fabry disease gene therapy acquisition, expanding rare disease pipeline. — impact context not separately stored; see What changed.
Sources